JPWO2020032027A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020032027A5 JPWO2020032027A5 JP2020535789A JP2020535789A JPWO2020032027A5 JP WO2020032027 A5 JPWO2020032027 A5 JP WO2020032027A5 JP 2020535789 A JP2020535789 A JP 2020535789A JP 2020535789 A JP2020535789 A JP 2020535789A JP WO2020032027 A5 JPWO2020032027 A5 JP WO2020032027A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- alzheimer
- amino acid
- disease
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 27
- 208000024827 Alzheimer disease Diseases 0.000 claims 19
- 229920001184 polypeptide Polymers 0.000 claims 18
- 102000004196 processed proteins & peptides Human genes 0.000 claims 18
- 108090000765 processed proteins & peptides Proteins 0.000 claims 18
- 241001465754 Metazoa Species 0.000 claims 16
- 238000000034 method Methods 0.000 claims 16
- 208000031124 Dementia Alzheimer type Diseases 0.000 claims 8
- 150000001413 amino acids Chemical class 0.000 claims 6
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 2
- 230000002250 progressing effect Effects 0.000 claims 2
- 210000003296 saliva Anatomy 0.000 claims 2
- 210000001138 tear Anatomy 0.000 claims 2
- 210000002700 urine Anatomy 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024014251A JP7654126B2 (ja) | 2018-08-07 | 2024-02-01 | アルツハイマー病の判定薬および判定方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018148924 | 2018-08-07 | ||
| JP2018148924 | 2018-08-07 | ||
| PCT/JP2019/030904 WO2020032027A1 (ja) | 2018-08-07 | 2019-08-06 | アルツハイマー病の判定薬および判定方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024014251A Division JP7654126B2 (ja) | 2018-08-07 | 2024-02-01 | アルツハイマー病の判定薬および判定方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020032027A1 JPWO2020032027A1 (ja) | 2021-09-09 |
| JPWO2020032027A5 true JPWO2020032027A5 (https=) | 2022-08-01 |
| JP7470041B2 JP7470041B2 (ja) | 2024-04-17 |
Family
ID=69413505
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020535789A Active JP7470041B2 (ja) | 2018-08-07 | 2019-08-06 | アルツハイマー病の判定薬および判定方法 |
| JP2024014251A Active JP7654126B2 (ja) | 2018-08-07 | 2024-02-01 | アルツハイマー病の判定薬および判定方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024014251A Active JP7654126B2 (ja) | 2018-08-07 | 2024-02-01 | アルツハイマー病の判定薬および判定方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12000844B2 (https=) |
| EP (1) | EP3835424A4 (https=) |
| JP (2) | JP7470041B2 (https=) |
| KR (1) | KR20210041035A (https=) |
| CN (1) | CN112567039B (https=) |
| AU (1) | AU2019318888A1 (https=) |
| CA (1) | CA3108440A1 (https=) |
| MX (1) | MX2021001507A (https=) |
| TW (1) | TW202035438A (https=) |
| WO (1) | WO2020032027A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115066610A (zh) * | 2020-02-05 | 2022-09-16 | 住友制药株式会社 | 用于tau病变和痴呆相关疾病的确定试剂和确定方法 |
| AU2021218735A1 (en) * | 2020-02-13 | 2022-09-01 | Cognition Therapeutics, Inc. | Method of decreasing amyloid beta monomer levels in patients with cognitive decline |
| WO2023036105A1 (zh) * | 2021-09-09 | 2023-03-16 | 上海日馨医药科技股份有限公司 | 治疗神经退行性疾病的方法 |
| CN117447590B (zh) * | 2023-11-23 | 2024-04-26 | 中国检验检疫科学研究院 | 一种抗赤羽病病毒单克隆抗体、分泌抗赤羽病病毒单克隆抗体的杂交瘤细胞及其应用 |
| CN121272033A (zh) * | 2025-08-21 | 2026-01-06 | 广东益尔生物技术有限公司 | 一种Circ-sAPPα及sAPPα-199aa作为阿尔茨海默症的检测标志物的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005214382B2 (en) | 2004-02-19 | 2011-08-04 | Genentech, Inc. | CDR-repaired antibodies |
| SG191620A1 (en) | 2008-07-08 | 2013-07-31 | Sumitomo Bakelite Co | Positive photosensitive resin composition, cured film, protecting film, insulating film, and semiconductor device and display device using the same |
| WO2010048497A1 (en) * | 2008-10-24 | 2010-04-29 | Genizon Biosciences Inc. | Genetic profile of the markers associated with alzheimer's disease |
| EP2660600B1 (en) | 2010-12-28 | 2018-08-08 | Sumitomo Dainippon Pharma Co., Ltd. | Diagnostic drug and diagnostic method for alzheimer's disease |
| CN109924024B (zh) | 2013-03-05 | 2021-11-23 | 现特技术有限公司 | 光子调制管理系统 |
| CN115066610A (zh) * | 2020-02-05 | 2022-09-16 | 住友制药株式会社 | 用于tau病变和痴呆相关疾病的确定试剂和确定方法 |
-
2019
- 2019-08-06 AU AU2019318888A patent/AU2019318888A1/en not_active Abandoned
- 2019-08-06 MX MX2021001507A patent/MX2021001507A/es unknown
- 2019-08-06 TW TW108127965A patent/TW202035438A/zh unknown
- 2019-08-06 KR KR1020217006577A patent/KR20210041035A/ko not_active Abandoned
- 2019-08-06 CA CA3108440A patent/CA3108440A1/en active Pending
- 2019-08-06 WO PCT/JP2019/030904 patent/WO2020032027A1/ja not_active Ceased
- 2019-08-06 US US17/265,805 patent/US12000844B2/en active Active
- 2019-08-06 CN CN201980052567.4A patent/CN112567039B/zh active Active
- 2019-08-06 EP EP19846675.7A patent/EP3835424A4/en not_active Withdrawn
- 2019-08-06 JP JP2020535789A patent/JP7470041B2/ja active Active
-
2024
- 2024-02-01 JP JP2024014251A patent/JP7654126B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020032027A5 (https=) | ||
| Wierer et al. | Compartment-resolved proteomic analysis of mouse aorta during atherosclerotic plaque formation reveals osteoclast-specific protein expression | |
| AU2009318813B2 (en) | Methods, devices and kits for detecting or monitoring acute kidney injury | |
| ES2702183T3 (es) | Identificación y monitorización de inmunoglobulinas monoclonales por masa molecular | |
| JP2026009931A (ja) | アルツハイマー病の無症状期を診断するためのバイオマーカーおよびその使用 | |
| JP2011503587A (ja) | 独特の分子形態を有するタンパク質バイオマーカーの診断における使用 | |
| JP2021512316A (ja) | 遺伝性血管性浮腫の診断方法 | |
| JPWO2008120684A1 (ja) | 急性中枢神経障害の予後判定方法 | |
| JPWO2021157634A5 (https=) | ||
| RU2015116674A (ru) | Способ диагностики или мониторинга почечной функции или диагностики почечной дисфункции | |
| KR20220133829A (ko) | 각막 내피 세포의 기능 부전 진단용 바이오마커 | |
| TWI519788B (zh) | Ｓｇｌｔ２作爲慢性腎臟疾病之診斷及追蹤治療後病況之生物標記 | |
| WO2015025975A1 (ja) | 糖尿病腎症の発症または発症リスクの検出方法及びキット | |
| RU2008103988A (ru) | Способ диагностики рассеяного склероза | |
| JP4573188B2 (ja) | 抗ｎｃ１モノクローナル抗体 | |
| WO2003089934A3 (de) | Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/lap-1 | |
| CN105510592A (zh) | 梗阻性肾病的蛋白标志物 | |
| WO2019128758A1 (zh) | 用于检测缺血性脑卒中血脑屏障早期损伤的抗体及其应用 | |
| CN107436321A (zh) | 心肌炎的蛋白标志物的用途 | |
| WO2019128759A1 (zh) | 用于检测缺血性脑卒中血脑屏障早期损伤的抗体及其应用 | |
| JP2021523680A5 (https=) | ||
| CN109342738B (zh) | 一组血清差异蛋白组合在制备用于检测阿尔茨海默症的试剂中的应用 | |
| JP7307479B2 (ja) | ＩｇＡ腎症診断用キット | |
| JP2022537448A5 (https=) | ||
| KR102882406B1 (ko) | 새우에 대한 아나필락시스 진단용 키트 |